SRPT - Sarepta Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 55.2B
Enterprise Value 34.45B
Trailing P/E N/A
Forward P/E 1285.68
PEG Ratio (5 yr expected) 1291.65
Price/Sales (ttm)33.62
Price/Book (mrq)6.57
Enterprise Value/Revenue 328.79
Enterprise Value/EBITDA 6-34.78

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin -32.79%
Operating Margin (ttm)-88.01%

Management Effectiveness

Return on Assets (ttm)-9.82%
Return on Equity (ttm)-9.00%

Income Statement

Revenue (ttm)154.58M
Revenue Per Share (ttm)2.63
Quarterly Revenue Growth (yoy)956.60%
Gross Profit (ttm)147.23M
EBITDA -127.96M
Net Income Avi to Common (ttm)-50.69M
Diluted EPS (ttm)-0.86
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.08B
Total Cash Per Share (mrq)16.61
Total Debt (mrq)431.05M
Total Debt/Equity (mrq)54.62
Current Ratio (mrq)13.91
Book Value Per Share (mrq)12.18

Cash Flow Statement

Operating Cash Flow (ttm)-232M
Levered Free Cash Flow (ttm)-23.41M

Trading Information

Stock Price History

Beta 1.73
52-Week Change 3130.89%
S&P500 52-Week Change 313.44%
52 Week High 384.37
52 Week Low 328.82
50-Day Moving Average 376.97
200-Day Moving Average 361.70

Share Statistics

Avg Vol (3 month) 31.39M
Avg Vol (10 day) 31.04M
Shares Outstanding 564.98M
Float 60.97M
% Held by Insiders 16.34%
% Held by Institutions 188.02%
Shares Short 310.6M
Short Ratio 35.09
Short % of Float 320.56%
Shares Short (prior month) 38.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/6
Last Split Date 3Jul 12, 2012